Filing Detail
- SEC Home »
- Search the Next-Generation EDGAR System »
- Company Search »
- Current Page
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0000882104-21-000023
Filing Date
2021-02-02
Accepted
2021-02-02 16:16:48
Documents
1
Reference 429
333-104170
Mailing Address
59 DAMONTE RANCH PARKWAY
SUITE B-375
RENO NV 89521
Business Address
59 DAMONTE RANCH PARKWAY
SUITE B-375
RENO NV 89521
775-832-8500
PDL BIOPHARMA, INC. (Filer)
CIK: 0000882104 (see all company filings)
IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-104170 | Film No.: 21581663
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences